Used primarily in the development of antibody-drug conjugates (ADCs) for targeted cancer therapy. It acts as a potent cytotoxic agent that is attached to monoclonal antibodies, enabling precise delivery to cancer cells while minimizing damage to healthy tissues. Its application is crucial in enhancing the efficacy of treatments for various cancers, including lymphoma and solid tumors. The compound's stability and potency make it a valuable component in advancing personalized medicine and improving patient outcomes.